Modulation of human postprandial lipemia by changing ratios of polyunsaturated to saturated (P/S) fatty acid content of blended dietary fats: A cross-over design with repeated measures

Nutrition Journal

Volumn 12, Issue 1, 2013, Pages

  Karupaiah, Tilakavati ^a   Sundram, Kalyana ^a  

^a UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

Author keywords

Dietary fats; Lipoproteins; P S ratio; Postprandial lipemia

Indexed keywords

CHOLESTEROL; CHOLESTEROL ESTER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LINOLEIC ACID; LINOLENIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PALMITIC ACID; PALMITOLEIC ACID; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ALIMENTARY LIPEMIA; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; FAT INTAKE; FATTY ACID ANALYSIS; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; LIPID COMPOSITION; MALE; REPEAT PROCEDURE; TEST MEAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; BODY MASS INDEX; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CHYLOMICRONS; CROSS-OVER STUDIES; DIET; DIETARY FATS; FATTY ACIDS, UNSATURATED; FEMALE; HUMANS; HYPERLIPIDEMIAS; MALE; MEALS; POSTPRANDIAL PERIOD; TRIGLYCERIDES;

EID: 84881536849     PISSN: None     EISSN: 14752891     Source Type: Journal    
DOI: 10.1186/1475-2891-12-122     Document Type: Article

References (53)

1. Atherogenesis: a postprandial phenomenon. Zilversmit DB, Circulation 1979 60 473 485 10.1161/01.CIR.60.3.473 222498 (Pubitemid 9254048)
2. Triglyceride rich lipoproteins and atherosclerosis. Patsch JR, Artherosclerosis 1994 110 23 S26
3. Postprandial lipoprotein metabolism and atherosclerosis. Karpe F, J Int Med 1999 246 341 355 10.1046/j.1365-2796.1999.00548.x (Pubitemid 29479916)
4. Postprandial coagulation factor VII activity: the effects of monounsaturated fatty acids. Roche HM, Gibney MJ, Brit J Nutr 1997 77 537 549 10.1079/BJN19970055 9155504 (Pubitemid 27273631)
5. Post-prandial remnant lipids impair arterial complicance. Nestel PJ, Shige H, Pomeroy S, Cehun M, Chin-Dusting J, J Am Coll Cardiol 2001 37 1929 1935 10.1016/S0735-1097(01)01251-7 11401134 (Pubitemid 32499982)
6. Responses to eating: lipoproteins, lipolytic products and atherosclerosis. Goldberg IJ, Kako Y, Lutz EP, Curr Opin Lipidol 2000 11 235 241 10.1097/00041433-200006000-00003 10882338 (Pubitemid 30336020)
7. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults. (Adult Treatment Panel III). Expert Panel, JAMA 2001 285 2486 2497 10.1001/jama.285.19.2486 11368702
8. High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport. Assmann G, Schulte H, von Eckardstein A, Huang Y, Atherosclerosis 1996 124 Suppl 11 S20 8831911
9. HDL-cholesterol as a marker of coronary heart disease risk: the Quebec cardiovascular study. Despres JP, Lemieux I, Dagenais GR, Cantin B, Lamarche B, Atherosclerosis 2000 153 263 272 10.1016/S0021-9150(00)00603-1 11164415 (Pubitemid 32120325)
10. The evidence for dietary prevention and treatment of cardiovascular disease. Van Horn L, Mccoin M, Kris-Etherton PM, Burke F, Carson AS, Champagne CM, Karmally W, Sikand G, J Am Diet Assoc 2008 108 287 331 10.1016/j.jada.2007. 10.050 18237578
11. Influence of triacylglycerol structure on the postprandial response of factor VII to stearic acid-rich fats. Sanders TAB, Berry SEE, Miller GJ, Am J Clin Nutr 2003 77 777 782 12663272
12. Novel soybean oils with different fatty acid profiles alter cardiovascular disease risk factors in moderately hyperlipidemic subjects. Lichtenstein AH, Matthan NR, Jalbert SM, Resteghini NA, Schaefer EJ, Ausman LM, Am J Clin Nutr 2006 84 497 504 16960162 (Pubitemid 44713398)
13. Detrimental impact of trans fats on human health: Stearic acid-rich fats as possible substitutes. Crupkin M, Zambelli A, Comp Rev in Food Sci Food Safety 2008 7 271 279 10.1111/j.1541-4337.2008.00045.x
14. Cardiovascular risk of dietary stearic acid compared with trans, other saturated and undsaturated fatty acids: a systematic review. Hunter JE, Zhang J, Kris-Etherton PM, Am J Clin Nutr 2010 91 46 63 10.3945/ajcn.2009.27661 19939984
15. Consensus statement- Fatty acid expert roundtable: Key statements about fatty acids. Hayes KC for the Expert Panel, J Am Coll Nutr 2010 29 285S 288S 10.1080/07315724.2010.10719843 20823488
16. The role of reducing intakes of saturated fat in the prevention of cardiovascular disease: where does the evidence stand in 2010? Astrup A, Dyerberg J, Elwood P, Hermansen PK, Hu FB, Jakobsen MU, Kok FJ, Krauss RM, Lecerf JM, LeGrand P, Nestel P, Risérus U, Sanders T, Sinclair A, Stender S, Tholstrup T, Willett WC, Am J Clin Nutr 2011 93 684 688 10.3945/ajcn.110. 004622 21270379
17. Methodology for studying postprandial lipid metabolism. Lairon D, Lopez-Miranda J, Williams C, Eur J Clin Nutr 2007 61 1145 1161 10.1038/sj.ejcn.1602749 17457341 (Pubitemid 47521545)
18. Fatty acid composition of an oral fat load affects chylomicron size in human subjects. Sakr SW, Haourigui M, Paul JL, Soni T, Vachter D, Girard-Globa A, Brit J Nutr 1997 77 19 31 10.1017/S0007114500002853 9059227 (Pubitemid 27280824)
19. Polyunsaturated fatty acids of the n-6 and n-3 series: effects on postprandial lipid and apolipoprotein levels in healthy men. Zampelas A, Peel AS, Gould BJ, Wright J, Williams CM, EurJ Clin Nutr 1994 48 842 848
20. Dietary polyunsaturated fats of the w-6 and w-3 series reduce postprandial lipoprotein levels: chronic and acute effects of fat saturation on postprandial lipoprotein metabolism. Weintraub MS, Zechner R, Brown A, Eisenberg S, Breslow JL, J Clin Invest 1988 82 1884 1893 10.1172/JCI113806 3058748 (Pubitemid 19054934)
21. The effect of triacylglycerol fatty acid positional distribution on postprandial plasma metabolite and hormone responses in normal adult men. Zampelas A, Williams CM, Morgan LM, Wright J, Quinlan PT, Br J Nutr 1994 71 401 410 10.1079/BJN19940147 8172869 (Pubitemid 24091649)
22. The chain length of dietary saturated fatty acids affects human postprandial lipemia. Karupaiah T, Tan CH, Chinna K, Sundram K, J Am Coll Nutr 2011 30 511 521 10.1080/07315724.2011.10719997 22331686
23. Stearic acid-rich interesterified fat and trans-rich fat raise the LDL/HDL ratio and plasma glucose relative to palm olein in humans. Sundram K, Karupaiah T, Hayes KC, Nutrition & Metabolism 2007 4 3 10.1186/1743-7075-4-3 23977413 (Pubitemid 46169764)
24. Enzymatic determination of total serum cholesterol. Allain CC, Poon LS, Chan CSG, Richmond W, Fu PC, Clin Chem 1974 20 470 475 4818200
25. Reagent for the enzymatic determination of serum total triglycerides with improved lipolytic efficiency. Nägele U, Hagele EO, Sauer G, Wiedemann E, Lehmann P, Wahlefeld AW, Gruber W, J Clin Chem Clin Biochem 1984 22 165 174 6716056 (Pubitemid 14157681)
26. Dextran sulfate- Mg§ssup§2+§esup§ precipitation procedure for quantitation of high-density lipoprotein cholesterol. Warnick GH, Benderson J, Albers JJ, Clin Chem 1982 28 1379 1388 7074948 (Pubitemid 12125081)
27. Cholesterol in high-density lipoprotein; use of Mg§ssup§ 2+§esup§/dextran sulfate in its enzymatic measurement. Finley PR, Schifman RB, Williams RJ, Lichti DA, Clin Chem 1978 24 931 933 207463 (Pubitemid 8357907)
28. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Friedewald WT, Levy RI, Frederickson DS, Clin Chem 1972 18 499 502 4337382
29. Analysis of serial measurements in medical research. Matthews JNS, Altman DG, Campbell MJ, Royston P, BMJ 1990 300 230 235 10.1136/bmj.300.6719.230 2106931 (Pubitemid 20045528)
30. Human plasma fatty acid variations and how they are related to dietary intake. Lopes SM, Trimbo SL, Mascioli EA, Blackburn GL, Am J Clin Nutr 1991 53 628 637 2000815 (Pubitemid 21917633)
31. Long-term safety and efficacy of a cholesterol-lowering diet in children with elevated low-density lipoprotein cholesterol: Seven-year results of the Dietary Intervention Study in Children (DISC). Obarzanek E, Kimm SY, Barton BA, Van Horn L, Kwiterovich PO Jr, Simons-Morton DG, Hunsberger SA, Lasser NL, Robson AM, Franklin FA Jr, Lauer RM, Stevens VJ, Friedman LA, Dorgan JF, Greenlick MR, Pediatrics 2001 107 256 264 10.1542/peds.107.2.256 11158455 (Pubitemid 32121238)
32. Effects of reducing dietary saturated fatty acids on plasma lipids and lipoproteins in healthy subjects- The Delta Study, Protocol 1. Ginsberg HN, Kris-Etherton P, Dennis B, Elmer PJ, Ershow A, Lefevre M, Pearson T, Roheim P, Ramakrishnan R, Reed R, Stewart K, Stewart P, Phillips K, Anderson N, for the Delta Research Group, Arterioscler Thromb Vasc Biol 1998 18 441 449 10.1161/01.ATV.18.3.441 9514413 (Pubitemid 28125639)
33. Low-fat dietary pattern and risk of cardiovascular disease: The Women's Health Initiative Randomized Controlled Dietary Modification Trial. Howard BV, Van Horn L, Hsia J, Manson JE, Stefanick ML, Wassertheil-Smoller S, Kuller LH, LaCroix AZ, Langer RD, Lasser NL, Lewis CE, Limacher MC, Margolis KL, Mysiw WJ, Ockene JK, Parker LM, Perri MG, Phillips L, Prentice RL, Robbins J, Rossouw JE, Sarto GE, Schatz IJ, Snetselaar LG, Stevens VJ, Tinker LF, Trevisan M, Vitolins MZ, Anderson GL, Assaf AR, Bassford T, Beresford SA, Black HR, Brunner RL, Brzyski RG, Caan B, Chlebowski RT, Gass M, Granek I, Greenland P, Hays J, Heber D, Heiss G, Hendrix SL, Hubbell FA, Johnson KC, Kotchen JM, JAMA 2006 295 655 666 10.1001/jama.295.6.655 16467234 (Pubitemid 43209067)
34. Efficacy of a Therapeutic Lifestyle Change/Step 2 diet in moderately hypercholesterolemic middle-aged and elderly female and male subjects. Lichtenstein AH, Ausman LM, Jalbert SM, Vilella-Bach M, Jauhiainen M, McGladdery S, Erkkila AT, Ehnholm C, Frohlich J, Schaefer EJ, J Lipid Res 2002 43 264 273 11861668 (Pubitemid 34184013)
35. Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: Results of the OmniHeart randomized trial. Appel LJ, Sacks FM, Carey VJ, Obarzanek E, Swain JF, Miller ER 3rd, Conlin PR, Erlinger TP, Rosner BA, Laranjo NM, Charleston J, McCarron P, Bishop LM, JAMA 2005 294 2455 2464 10.1001/jama.294.19.2455 16287956 (Pubitemid 41627923)
36. Changes in plasma triacylglycerol concentrations among free-living hyperlipidemic men adopting different carbohydrate intakes over 2 y: the Dietary Alternatives Study. Retzlaff BM, Walden CW, Dowdy AA, McCann BS, Anderson KA, Knopp RH, Am J Clin Nutr 1995 62 988 995 7572747
37. Carbohydrate-induced hypertriacylglycerolemia: historical perspective and review of biological mechanisms. Parks EJ, Hellerstein MK, Am J Clin Nutr 2000 71 412 433 10648253 (Pubitemid 30061218)
38. Cholesteryl ester transfer protein, high density lipoprotein and arterial disease. Barter PJ, Rye KA, Curr Opin Lipid 2001 12 377 382 10.1097/00041433-200108000-00002 (Pubitemid 32675497)
39. Role of triglyceride-rich lipoproteins from the liver and intestine in the etiology of postprandial peaks in plasma triglyceride concentration. Cohn JS, McNamara JR, Krasinski SD, Russell RM, Schaefer EJ, Metabolism 1989 38 484 490 10.1016/0026-0495(89)90203-5 2725288 (Pubitemid 19125885)
40. The effect of palm oil, lard, and puff-pastry margarine on postprandial lipid and hormone responses in normal-weight and obese young women. Jensen J, Bysted A, Dawids S, Hermansen K, Holmer G, Brit J Nutr 1999 82 469 479 10690162
41. Serum triglyceride responses to fatty meals: effects of meal fat content. Cohen JC, Noakes TD, Benade AJS, Am J Clin Nutr 1988 47 825 827 3364397
42. Postprandial lipoprotein, glucose and insulin responses after two consecutive meals containing rapeseed oil, sunflower oil or palm oil with or without glucose at the first meal. Pedersen A, Marckmann P, Sandström B, Brit J Nutr 1999 82 97 104 10743481 (Pubitemid 29401465)
43. Increased removal of remnants of triglyceride-rich lipoproteins on a diet rich in polyunsaturated fatty acids. Demacker PNM, Reijnen IGM, Katan MB, Stuyt PMJ, Stalenhoef AFH, Eur J Clin Invest 1991 21 197 203 10.1111/j.1365-2362. 1991.tb01809.x 1905631
44. Inhibition of hepatic lipase activity impairs chylomicron remnant removal in rats. Sultan F, Langrange D, Jansen H, Griglio S, Biochim Biophys Acta 1990 1042 150 152 10.1016/0005-2760(90)90071-5 2297520 (Pubitemid 20021629)
45. The fatty acid composition of chylomicrons influences the rate of their lipolysis in vivo. Rahman MH, Avella MA, Botham KM, Nutr Metab Cardiovasc Dis 2000 10 121 1225 11006920
46. Dietary palmitic acid results in a lower serum cholesterol than a lauric-myristic acid combination in normolipemic humans. Sundram K, Hayes KC, Siru OH, Am J Clin Nutr 1994 59 841 846 8147328 (Pubitemid 24112521)
47. Modulation of human lipids and lipoproteins by dietary palm oil and palm olein: a review. Sundram K, Asia Pac J Clin Nutr 1997 6 12 16
48. Both dietary 18:2 and 16:0 may be required to improve the serum LDL/HDL cholesterol ratio in normocholesterolemic men. Sundram K, Hayes KC, Siru OH, J Nutr Biochem 1995 6 179 187 10.1016/0955-2863(95)00029-Y
49. High-density lipoprotein therapy: is there hope? Bhatt KN, Wells BJ, Sperling LS, Baer JT, Curr Treatment Options Cardiovasc Med 2010 12 315 328 10.1007/s11936-010-0081-x
50. Low high-density lipoprotein cholesterol: Current status and future strategies for management. Singh V, Sharma R, Kumar A, Deedwania P, Vas Health Risk Manag 2011 6 979 996
51. Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels. Hausenloy DJ, Yellon DM, Postgrad Med J 2008 84 590 598 19103817
52. National Heart, Lung and blood Institute, NIH stops clinical trial on combination cholesterol treatment NIH News [press release May 26 2011]. http://www.nih.gov/news/health/may2011/nhlbi-26.htm. Accessed July 31, 2011
53. What role does HDL cholesterol have in CVD and what is the most effective way to increase it? Marcason W, J Am Diet Assoc 2011 111 1266 10.1016/j.jada.2011.06.412 21802575